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ABSTRACT
A clinical descriptive study was done to determine the sociodemographic, laboratory and clinical 
characteristics of patients with congenital adrenal hyperplasia (CAH) referred to Hospital Putrajaya, a 
tertiary endocrine centre in Malaysia. Electronic laboratory data of 51 CAH patients were obtained. The 
demographics and clinical details of the study population were acquired from a questionnaire completed 
by parents of participants. There were 25 males (49%) and 26 females (51%), of which, 58.8% were 
Malays. Median age of participants was 4 years whilst median age at diagnosis of CAH was two years. 
Parental consanguinity was documented in three patients (5.9%). Patients originated from Johor (19.6%), 
Selangor (19.6%), Negeri Sembilan (17.6%) and Kedah (13.7%). Majority of patients were diagnosed 
after one week of life (80.4%) although more females were diagnosed under the age of one week 
compared to males (p=0.041). Most females presented with ambiguous genitalia (42.3%) [p=0.001] 
whereas 72% of males presented with salt wasting (p=0.003). No significant associations between race 
and all other variables, though interestingly three Malay patients presented with ambiguous genitalia 
and hypertension. Equal gender distribution noted as expected in an autosomal recessive condition, 
although not in keeping with other Asian countries. Early diagnosis in females attributed to obvious 
genital ambiguity at birth. Varied clinical presentation, although in minority, necessitates genetic studies 
for prompt diagnosis and treatment. Considering that majority of patients presented with salt wasting 
and the age at diagnosis was delayed, the introduction of a neonatal screening programme is essential 
in Malaysia. 
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INTRODUCTION
Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder of adrenal steroid hormone biosynthesis 
with two major phenotypes; classic and non-classic CAH. The most common form is due to 21-hydroxylase (21-OH) 
deficiency, which accounts for 95% of CAH. Classic CAH is the more severe form of the disease affecting very young 
children and can be subclassified as salt wasting (75%) or simple virilising (25%), reflecting the degree of aldosterone 
deficiency.1 Non-classical CAH is milder and usually presents during late childhood or early adulthood.2, 3
Clinical features of CAH depend upon the position of the defective enzyme in the steroid synthetic pathway, 
which determines the pattern of hormones and precursors produced.2 Mutation in 21-OH enzyme (CYP21A2) blocks 
conversion of 17-hydroxyprogesterone (17-OHP) to 11-deoxycortisol, which in turn causes adrenal insufficiency and 
compensatory elevation of adrenocorticotropic hormone (ACTH). ACTH elevation causes adrenal hyperplasia and 
additional precursor synthesis. Precursor excess is shunted into the androgen synthesis pathway, causing virilisation 
in females and premature sexual development in males. Adrenal crisis is a medical emergency in salt-wasting CAH, 
which usually occurs within 14 days of birth if the disorder is untreated.3, 4
The worldwide incidence of CAH due to 21-OH deficiency based on neonatal screening is 1:14,199 live births.4 
High rates of classic CAH have been reported in the Yupic Eskimos of Alaska, the French island of La Réunion, Brazil 
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and the Philippines.4 However, non-classic CAH is more common than classic CAH, with a frequency of one in 100 
in a heterogenous New York population5 and is more frequent in certain ethnic populations, such as Jews of Eastern 
European origin, Hispanics, and Yugoslavs.4
11-beta-hydroxylase (11β-OH) deficiency, the second most common cause of CAH, accounts for 5–8% of CAH 
patients and increased rates are found among Moroccan Jews.4 The incidence of 11β-OH deficiency was reported to 
be one in 100,000 among Caucasians.6 11β-OH deficiency impairs conversion of 11-deoxycortisol to cortisol. An 
accumulation of 11-deoxycorticosterone will lead to mineralocorticoid excess with hypertension. Affected female 
infants can present with ambiguous genitalia.7
Serum 17-OHP and androstenedione levels provide the most sensitive index of biochemical control. In cases 
where neonatal screening is not available and 21-OH deficiency is suspected clinically, a synacthen test with 
measurements of cortisol, 17-OHP and androgens before and one hour after exogenous administration of ACTH 
(0.25mg intravenous bolus of cosyntropin) can be performed after the first 24–48 hours of life. This test should not be 
performed during the initial 24 hours of life as it may give rise to false-positive results.2
To date there are limited data on CAH in Malaysian population. Considering the incidence of CAH varies 
according to ethnicity and geographical area, the imminent need to know the racial distribution in a multiethnic 
population like Malaysia is essential. Thus, the aim of this study is to determine the sociodemographic, biochemical and 
hormonal characteristics and the clinical presentation of CAH patients in selected paediatric population in Malaysia. 
MATERIALS AND METHODS
Fifty-one patients with a diagnosis of CAH were recruited into this clinical descriptive study during their 3 - 4 monthly 
clinic visits to the paediatric endocrine clinics at Hospital Putrajaya over a period of 12 months. Hospital Putrajaya is 
currently the tertiary paediatric endocrine centre in Malaysia. Informed written consent was obtained from parent of 
each subject who participated in this study, in accordance with the Helsinki Declaration. The study was approved by 
the Research and Ethics Committees of both Universiti Putra Malaysia (ref. no: UPM/FPSK/PADS/T7-MJKEtikaPer/
F01(JPAT_NOV(09)07 dated 04/03/2010) and the Ministry of Health Malaysia (NMRR09-474-4011). All patients 
diagnosed with CAH who were referred to the paediatric endocrine clinics at Hospital Putrajaya were included. The 
demographics and clinical details of the study population were obtained from a questionnaire completed by parents 
of participants. Pre- and post-treatment laboratory data were acquired from the electronic laboratory information 
systems of Hospital Putrajaya. Patients with unrecorded data (missing data) were excluded from statistical analysis. 
Confidentiality of patients was ensured. 
Routine biochemical tests, such as sodium and potassium, were measured by standard laboratory methods on 
an automated biochemistry analyser, Synchron LX20 Pro (Beckman Coulter, Massachusetts, USA). Serum cortisol 
was determined by electrochemiluminescence immunoassay on the Roche Cobas e411 analyser (Roche Diagnostics, 
Mannheim, Germany). Serum 17-OHP and plasma renin were measured using DPC Gamma Counter C-12 (Diagnostics 
Products Corporation, California USA). Serum testosterone and ACTH were measured by chemiluminescence 
immunoassay on IMMULITE® 2000 XPi system (Siemens Medical Solutions Diagnostics, Erlangen, Germany).
Statistical calculations were performed using the standard statistical software package, IBM SPSS Statistics 
for Windows, Version 21.0. Armonk, NY: IBM Corp. Shapiro-Wilk test was used to assess sample distribution due 
to small sample size (less than 100). Skewness and kurtosis values were also used to assess normality of data. Non-
parametric tests were used for analysis of variables as they were not normally distributed, and median values with 25 
to 75 percentiles were used. Mann-Whitney U test and/or Kruskall Wallis test were used to test the probability of any 
significant difference between groups. Associations between qualitative variables were determined by Chi-square test, 
Fisher’s exact test and SAS Exact Contingency Table. In all statistical analyses, p value of < 0.05 (95% confidence 
interval) was considered to be statistically significant. 
RESULTS
The demographics and clinical details of the study population (n = 51) are summarised in Table 1. There were 25 
males (M) (49%) and 26 females (F) (51%). Majority were Malays (58.8%) - 15M, 15F; 29.4% were Chinese (7M, 
8F); 7.8% were Indian (1M, 3F) and 3.9% of other races were categorised under Others (2M). Median age of patients 
was 4.1 years with an interquartile range (IQR) of 6, ranging from 1 to 16 years whilst median age at diagnosis of 
CAH was two years (IQR = 1), ranging from 0 to 4 years. Parental consanguinity was documented in three patients 
(5.9%). Majority were diagnosed after one week of life (80.4%). 31 families had only one child affected with CAH 
(17 Malays, 8 Chinese, 4 Indians, 2 others), 17 families had two children with CAH (10 Malays & 7 Chinese) while 
three Malay families had three children with CAH. 
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The patients mainly originated from Johor (19.6%), Selangor (19.6%), Negeri Sembilan (17.6%) and Kedah 
(13.7%). However, the highest percentage of CAH diagnosis was made at Hospital Tuanku Jaafar, Seremban, Negeri 
Sembilan (15.7%). Forty-one patients (80.4%) were further investigated for CAH based on clinical presentation 
whereas the other 10 (19.6%) were based on a positive family history. Clinical presentation comprised of ambiguous 
genitalia (23.5%), ambiguous genitalia and salt wasting (5.9%), ambiguous genitalia and hypertension (5.9%) simple 
virilising (13.7%) and salt wasting (51%). For the laboratory investigations of the study population, the number of 
patients (n) differed for each analyte due to unrecorded data and thus were not included in statistical analysis (Table 2).
Table 1.Summary of demographic and clinical details of the study population
Characteristic  n (%)
Gender 
Male 
Female
25 (49)
26 (51)
Race 
Malay
Non – Malay 
30 (58.8)
21 (41.2)
State of origin
Johor
Selangor
Negeri Sembilan
Kedah
Kelantan
Pahang
Pulau Pinang
Perak
Terengganu
Sabah
Sarawak
Kuala Lumpur
10 (19.6)
10 (19.6)
9 (17.6)
7 (13.7)
4 (7.8)
3 (5.9)
3 (5.9)
1 (2.0)
1 (2.0)
1 (2.0)
1 (2.0)
1 (2.0)
Age at diagnosis 
<  1 week
> 1 week
10 (19.6)
41 (80.4)
Reason for further investigation of CAH 
Positive family history of CAH
Clinical presentation of CAH
10 (19.6)
41 (80.4)
Parental consanguinity 
No
Yes
48 (94.1)
3 (5.9)
Clinical Presentation
Salt wasting 
Ambiguous genitalia
Simple virilising
Ambiguous genitalia & salt wasting
Ambiguous genitalia & hypertension
26 (51.0)
12 (23.5)
7 (13.7)
3 (5.9)
3 (5.9)
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Table 2. Summary of laboratory findings of the study population 
  
* the number of patients (n) differed for each analyte due to unrecorded data (missing data)
Majority of patients were diagnosed after 1 week of life (80.4%) although more females were diagnosed under 
the age of 1 week compared to males (p=0.041). Most females presented with ambiguous genitalia (42.3%) [p=0.001] 
whereas 72% of males presented with salt wasting (p=0.003) [Table 3]. There were no significant associations between 
race and clinical presentation, age of diagnosis or any of the analytes, although, interestingly three Malay patients 
presented with ambiguous genitalia and hypertension. 
Analyte
(Serum)
n* 
(51)
Median (IQR) Min - Max Reference range
Sodium (mmol/L)
Potassium (mmol/L)
Renin (ng/ml/hr)
ACTH (pg/ml)
17-OHP (nmol/L)
Pre-treatment
Post-treatment
9am Cortisol (nmol/L)
Pre-treatment
Post-treatment
Testosterone (nmol/L)
Pre-treatment
Post-treatment
ACTH Stimulation Test 
(nmol/L)
Cortisol 0m
Cortisol 30m
Cortisol 60m
17OHP 0m
17OHP 30m
17OHP 60m
34
34
43
36
29
29
20
20
26
26
27
27
27
26
26
26
133.9 (16.9)
         
6.2 (2.5)
9.7 (40.6)
35.7 (162.8)
269.5 (669.4)
10.6 (83.3)
56.4 (74.6)
213.4 (283.0)
11.6 (28.7)
0.7 (2.1)
125.7 (175.5)
182.6 (651.2)
420.0 (791.2)
28.3 (299.0)
46.3 (503.6)
60.7 (429.1)
99 – 142
3.5 – 44.3
0.2 – 1091.0
2.3 – 2275.0
0.3 – 2356.4
0.1 – 425.3
10 – 305
74.5 – 2883.9
0.7 – 331.7
0.5 – 31.3
2.0 – 715.9
19.8 – 1431.0
25.5 – 1750.5
0.1 – 1796.5
0.6 – 2449.8
0.6 – 2035.9
135 – 145 
3.0 – 5.0 
Supine 0.2 - 2.8 
Upright 1.5 – 5.7
< 10.1
Male 1.3 – 10.6 
Females: 
1.59 – 48     3 days to 3 months
<3.3        3 month to 5 years
<3.0        6 to 11 years
<6.0        12 to 20 years
119 – 618 [am]
Female: 
<2.0   0 to 6 months
<1.0   2 months to 10 years
<1.5   10 years to 12 years
1 - 2   12 years to 14 years
1 – 2.5 >14 years
Male: 
5 - 12    at birth
1 - 2    5 to 6 days
7 - 12    30 to 60 days
< 1.0    7 months to 10 years
1 – 3.5    12 years to 14 years 
3 - 13 >14 years
Normal result: Increment in 
cortisol of 200 nmol/L with 
peak of > 550 nmol/L post 
ACTH stimulation.
< 45 
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Table 3. Associations between gender with age at diagnosis and clinical presentation
Since n > 20 and there is no expected value less than 5, Pearson Chi-Square is used.
  *Statistical significance at p < 0.05
  The significant variables are shown in bold.
DISCUSSION
The incidence of CAH in Asian populations is approximately 1:44,000,5 which is relatively lower compared to 
worldwide figures. In 1994, a case survey in Malaysia using the birth rate of the Maternity Hospital- and the patients 
referred to the Paediatric Endocrine Unit of Hospital Kuala Lumpur found that the overall incidence of CAH was 
1:3,000 with approximately equal distribution among the Malay, Chinese and Indian populations, comprising 57%, 
16%, and 13%, respectively.8 In comparison, our study showed no significant change in distribution of CAH in 
Malay patients (58.8%), an increase in Chinese patients (29.4%) and a decrease in Indian patients (7.8%). Our study 
also took into account other ethnicities, which made up 3.9% of CAH patients. Wu et al. (1994) partially attributed 
this unexpected high incidence of a potentially salt-wasting disorder in a tropical country to consanguinity which is 
frequent in the Malay- and Indian-, but not in the Chinese community. However, in our study parental consanguinity 
was only documented in three patients, of whom two were Malays and one from other ethnicity. Furthermore, no 
significant association was found between ethnicity and consanguinity. Wu et al. (1994) also hypothesised selective 
advantage of the heterozygote state as a possible cause. 
As expected in an autosomal recessive disorder, there was equal gender distribution among CAH patients in this 
study; 25 males (49%) and 26 females (51%). However, other retrospective studies in South East Asia have reported 
skewed male: female ratios, with female preponderance; rationale given was that the clinical manifestation was more 
obvious in females, hence the earlier consult.9
In this study, although majority of patients were diagnosed after one week of life (80.4%), more females were 
diagnosed under the age of one week compared to males (p=0.041). The significant difference in the age at diagnosis 
between genders could be explained by the significant association between gender and clinical presentation (Table 3). 
Most females (42.3%) presented with ambiguous genitalia whereas 72% of males presented with salt wasting. 
Female infants with classic CAH typically have genital ambiguity at birth because of exposure to high 
concentrations of androgens in utero. Characteristic findings include an enlarged clitoris, partly fused and rugated 
labia majora, and a common urogenital sinus in place of a separate urethra and vagina. The internal female organs, the 
uterus, fallopian tubes, and ovaries, are normal. Male infants however have no obvious signs of CAH at birth, except 
hyperpigmentation and possible subtle penile enlargement.4 Thus, it is probably the ambiguous genitalia in females at 
birth that typically lead to early diagnosis and treatment. 
Affected males may go undetected for several years, until symptoms and signs of androgen excess develop. 
The age at diagnosis in boys varies according to the severity of aldosterone deficiency. Patients with severe salt 
wasting present at 2–3 weeks of life with adrenal crises, which includes vomiting, weight loss, lethargy, dehydration, 
hyponatraemia, hyperkalaemia and shock. This problem is particularly critical in male infants who have no genital 
ambiguity to alert physicians to the possibility of CAH.4, 7
Parameter Male
(n = 25) (%)
Female
(n = 26) (%)
c2 p -value
Age at diagnosis 
(% within gender)
< 1 week of life
> 1 week of life
2 (8)
23 (92)
8 (30.8)
18 (69.2)
4.192 0.041*
Clinical presentation (C/P)
(% within gender)
Ambiguous genitalia
Ambiguous genitalia & salt wasting
Ambiguous genitalia & hypertension 
Simple virilising
Salt wasting
1 (4)
0 (0)
1 (4)
5 (20)
18 (72)
11 (42.3)
3 (11.5)
2 (7.7)
2 (7.7)
8 (30.8)
10.395
3.065
0.314
1.630
8.670
0.001*
0.08
0.575
0.202
0.003*
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Congenital adrenal hyperplasia due to 11β-OH deficiency accounts for less than 8% of cases. Clinical features 
include glucocorticoid deficiency, excessive adrenal androgen secretion, hypertension, and hypokalaemia. In this 
study, although not significant, it was interesting to note that three patients presented with ambiguous genitalia and 
hypertension and that they were all Malays. Whether this particular mutation is more common in the Malay community 
should be further confirmed with genetic studies. 
From this study, we were able to ascertain the states in Malaysia where majority of CAH patients originated 
from. Whether a particular mutation is more prevalent in that community or the earlier diagnosis is due to a more 
vigilant medical team in that state hospital or that the society itself is more educated and aware of the condition needs 
to be established. 
Laboratory results of the study population were as anticipated for a CAH patient (Table 2). Median levels for pre-
treated sodium and potassium were 133.9 mmol/L and 6.2 mmol/L, respectively, fitting the picture of hyponatraemia 
and hyperkalaemia, related to hypoaldosteronism. Median levels of pre-treated serum renin activity, 9.7 ng/ml/hr and 
serum ACTH, 35.7 pg/ml were raised as expected. In this study the median level of pre-treated 17-OHP was 269.5 
nmol/L. A very high concentration of 17-OHP (more than 242 nmol/L; normal less than 3 nmol/L at 3 days in full-
term infant) in a randomly timed blood sample is diagnostic of classic 21-OH deficiency.4 In ACTH stimulation test 
(synacthen test), a stimulated concentration of 17-OHP higher than 45 nmol/L is diagnostic of 21-OH deficiency.4 
In this study, median level of stimulated 17-OHP was 46.3 nmol/L and 60.6 nmol/L at 30 minutes and 60 minutes, 
respectively. Serum cortisol showed a blunted response to ACTH stimulation, confirming adrenal insufficiency. 
Furthermore, the post-treatment levels of serum 17-OHP, cortisol, and testosterone, have increased and decreased 
accordingly, reflecting the effectiveness of treatment. 
CONCLUSION
We were unable to estimate the prevalence of CAH in Malaysia due to the limitation of this study being conducted in a 
single site tertiary centre and the small sample size. Based on the clinical and laboratory findings, the majority of CAH 
patients were likely to have 21-OH deficiency, the most common form of classic CAH. However, there were three 
patients who presented with ambiguous genitalia and hypertension, pointing to a diagnosis of 11β-OH deficiency. 
Thus, detailed biochemical and genetic studies should be done as part of management to further confirm the diagnosis 
in these patients. Considering that the age at diagnosis is delayed in the study population, it is imperative that the 
reason/s for the delay in diagnosis be ascertained to ensure timely treatment and avoidance of complications. More 
effort is also required to educate the public regarding the disease presentation. The introduction of a neonatal screening 
programme in Malaysia is essential so that CAH can be diagnosed early leading to fewer patients presenting with life-
threatening adrenal crisis. This will ultimately lead to an improvement in the management of CAH patients, resulting 
in a better quality of life, lower morbidity and mortality, and finally a reduction in the health care cost in our country. 
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